Common use of Amgen Publication Clause in Contracts

Amgen Publication. Amgen shall have the right to publish those publications in planning stage as of the Effective Date, including those listed in Exhibit G; provided, however, that any other publication regarding the Product or that discloses Confidential Information of BioAge shall require BioAge’s prior written consent, such consent not to be unreasonably withheld, conditioned or delayed. The Parties acknowledge and agree that all Amgen publications pursuant to this section shall be developed by Amgen in accordance with Amgen’s publications policies and practices.

Appears in 2 contracts

Sources: Exclusive License Agreement (BioAge Labs, Inc.), Exclusive License Agreement (BioAge Labs, Inc.)